litlas
ログインアカウント作成

A. John Iafrate

1997–2026 年に発表

別表記
A.John Iafrate
229
論文数
75,737
被引用数
127
h 指数
224
i10 指数

被引用数

A. John Iafrate の年別被引用数1945 年: 被引用 1 件1976 年: 被引用 2 件1985 年: 被引用 2 件1987 年: 被引用 1 件1990 年: 被引用 1 件1993 年: 被引用 1 件1994 年: 被引用 2 件1995 年: 被引用 1 件1997 年: 被引用 3 件1998 年: 被引用 19 件1999 年: 被引用 20 件2000 年: 被引用 30 件2001 年: 被引用 27 件2002 年: 被引用 18 件2003 年: 被引用 12 件2004 年: 被引用 15 件2005 年: 被引用 64 件2006 年: 被引用 85 件2007 年: 被引用 111 件2008 年: 被引用 211 件2009 年: 被引用 294 件2010 年: 被引用 408 件2011 年: 被引用 687 件2012 年: 被引用 969 件2013 年: 被引用 1,058 件2014 年: 被引用 966 件2015 年: 被引用 1,162 件2016 年: 被引用 1,111 件2017 年: 被引用 1,232 件2018 年: 被引用 1,199 件2019 年: 被引用 2,927 件2020 年: 被引用 3,182 件2021 年: 被引用 3,221 件2022 年: 被引用 2,730 件2023 年: 被引用 1,606 件2024 年: 被引用 2,160 件2025 年: 被引用 1,019 件2026 年: 被引用 27 件1946〜1975 年は被引用が無いため表示していません1977〜1984 年は被引用が無いため表示していません1986 年は被引用が無いため表示していません1988〜1989 年は被引用が無いため表示していません1991〜1992 年は被引用が無いため表示していません1996 年は被引用が無いため表示していません

引用元

国・地域

この著者を引用した国・地域の世界地図アメリカ合衆国: 引用元論文 9,269 件、この内訳の 29.9%中国: 引用元論文 3,364 件、この内訳の 10.9%イギリス: 引用元論文 1,790 件、この内訳の 5.8%ドイツ: 引用元論文 1,617 件、この内訳の 5.2%イタリア: 引用元論文 1,517 件、この内訳の 4.9%日本: 引用元論文 1,178 件、この内訳の 3.8%フランス: 引用元論文 1,112 件、この内訳の 3.6%カナダ: 引用元論文 1,010 件、この内訳の 3.3%スペイン: 引用元論文 855 件、この内訳の 2.8%オランダ: 引用元論文 768 件、この内訳の 2.5%韓国: 引用元論文 725 件、この内訳の 2.3%スイス: 引用元論文 719 件、この内訳の 2.3%
0%29.9%その他 22.7%

機関

分野

  • Medicine56.2%
  • Biochemistry, Genetics and Molecular Biology36.6%
  • Immunology and Microbiology2%
  • Engineering1.2%
  • Computer Science0.9%
  • Agricultural and Biological Sciences0.7%
  • その他2.4%

トピック

  • Lung Cancer Treatments and Mutations7.6%
  • Cancer Genomics and Diagnostics6.2%
  • Lung Cancer Research Studies3.3%
  • CRISPR and Genetic Engineering2.6%
  • Cancer Cells and Metastasis2.5%
  • Glioma Diagnosis and Treatment2.5%
  • その他75.3%

共著者

全論文

検索で開く
  1. GUIDE-seq enables genome-wide profiling of off-target cleavage by CRISPR-Cas nucleases

    著者: Shengdar Q. Tsai, Zongli Zheng, Nathalie T. Nguyen, Matthew Liebers, Ved V. Topkar, Vishal Thapar, Nicolas Wyvekens, Cyd Khayter, A. John Iafrate, Long P. Le, Martin J. Aryee, J. Keith Joung - Nature Biotechnology 2014 被引用: 2,307

  2. Single-cell RNA-seq supports a developmental hierarchy in human oligodendroglioma

    著者: Itay Tirosh, Andrew S. Venteicher, Christine Hebert, Leah E. Escalante, Anoop P. Patel, Keren Yizhak, Jonathan Fisher, Christopher Rodman, Christopher Mount, Mariella G. Filbin, Cyril Neftel, Niyati Desai, Jackson Nyman, Benjamin Izar, Christina C. Luo, Joshua M. Francis, Aanand A. Patel, Maristela L. Onozato, Nicolò Riggi, Kenneth J. Livak, Dave Gennert, Rahul Satija, Brian V. Nahed, William T. Curry, Robert L. Martuza, Ravindra Mylvaganam, A. John Iafrate, Matthew P. Frosch, Todd R. Golub, Miguel N. Rivera, Gad Getz, Orit Rozenblatt–Rosen, Daniel P. Cahill, Michelle Monje, B Bernstein, David N. Louis, Aviv Regev, Mario L. Suvà - Nature 2016 被引用: 1,372

  3. Decoupling genetics, lineages, and microenvironment in IDH-mutant gliomas by single-cell RNA-seq

    著者: Andrew S. Venteicher, Itay Tirosh, Christine Hebert, Keren Yizhak, Cyril Neftel, Mariella G. Filbin, Volker Hovestadt, Leah E. Escalante, McKenzie Shaw, Christopher Rodman, Shawn Gillespie, Danielle Dionne, Christina C. Luo, Hiranmayi Ravichandran, Ravindra Mylvaganam, Christopher Mount, Maristela L. Onozato, Brian V. Nahed, Hiroaki Wakimoto, William T. Curry, A. John Iafrate, Miguel N. Rivera, Matthew P. Frosch, Todd R. Golub, Priscilla K. Brastianos, Gad Getz, Anoop P. Patel, Michelle Monje, Daniel P. Cahill, Orit Rozenblatt–Rosen, David N. Louis, B Bernstein, Aviv Regev, Mario L. Suvà - Science 2017 被引用: 1,090

  4. Genotypic and Histological Evolution of Lung Cancers Acquiring Resistance to EGFR Inhibitors

    著者: Lecia V. Sequist, Belinda A. Waltman, Dora Dias‐Santagata, Subba R. Digumarthy, Alexa B. Turke, Panos Fidias, Kristin Bergethon, Alice T. Shaw, Scott Gettinger, Arjola K. Cosper, Sara Akhavanfard, Rebecca S. Heist, Jennifer S. Temel, James G. Christensen, John C. Wain, Thomas J. Lynch, Kathy Vernovsky, Eugene J. Mark, Michael Lanuti, A. John Iafrate, Mari Mino–Kenudson, Jeffrey A. Engelman - Science Translational Medicine 2011 被引用: 3,556

  5. Tumor cells can follow distinct evolutionary paths to become resistant to epidermal growth factor receptor inhibition

    著者: Aaron N. Hata, Matthew J. Niederst, Hannah L. Archibald, María Gomez‐Caraballo, Faria M. Siddiqui, Hillary E. Mulvey, Yosef E. Maruvka, Fei Ji, Hyo-Eun Carrie Bhang, Viveksagar Krishnamurthy Radhakrishna, Giulia Siravegna, Haichuan Hu, Sana Raoof, Elizabeth L. Lockerman, Anuj Kalsy, Dana Lee, Celina L Keating, David A. Ruddy, Leah J. Damon, Adam Crystal, Carlotta Costa, Zofia Piotrowska, Alberto Bardelli, A. John Iafrate, Ruslan I. Sadreyev, Frank Stegmeier, Gad Getz, Lecia V. Sequist, Anthony C. Faber, Jeffrey A. Engelman - Nature Medicine 2016 被引用: 999

  6. Crizotinib in ROS1-Rearranged Non–Small-Cell Lung Cancer

    著者: Alice T. Shaw, Sai‐Hong Ignatius Ou, Yung‐Jue Bang, D. Ross Camidge, Benjamin Solomon, Ravi Salgia, Gregory J. Riely, Marileila Varella‐Garcia, Geoffrey I. Shapiro, Daniel B. Costa, Robert C. Doebele, Long P. Le, Zongli Zheng, Weiwei Tan, Patricia Stephenson, S. Martin Shreeve, L. Tye, James G. Christensen, Keith D. Wilner, Jeffrey W. Clark, A. John Iafrate - New England Journal of Medicine 2014 被引用: 1,993

  7. Using Multiplexed Assays of Oncogenic Drivers in Lung Cancers to Select Targeted Drugs

    著者: Mark G. Kris, Bruce E. Johnson, Lynne D. Berry, David J. Kwiatkowski, A. John Iafrate, Ignacio I. Wistuba, Marileila Varella‐Garcia, Wilbur A. Franklin, Samuel L. Aronson, Pei-Fang Su, Yu Shyr, D. Ross Camidge, Lecia V. Sequist, Bonnie S. Glisson, Fadlo R. Khuri, Edward B. Garon, William Pao, Charles M. Rudin, Joan H. Schiller, Eric B. Haura, Mark A. Socinski, Keisuke Shirai, Heidi Chen, Giuseppe Giaccone, Marc Ladanyi, Kelly Kugler, John D. Minna, Paul A. Bunn - JAMA 2014 被引用: 1,744

  8. Liquid versus tissue biopsy for detecting acquired resistance and tumor heterogeneity in gastrointestinal cancers

    著者: Aparna R. Parikh, Ignaty Leshchiner, Liudmila Elagina, Lipika Goyal, Chaya Levovitz, Giulia Siravegna, Dimitri Livitz, Kahn Rhrissorrakrai, Elizabeth E. Martin, Emily E. Van Seventer, Megan Hanna, Kara Slowik, Filippo Utro, Christopher J. Pinto, Alicia Wong, Brian P. Danysh, Ferran Fece de la Cruz, Isobel J. Fetter, Brandon Nadres, Heather A. Shahzade, Jill N. Allen, Lawrence S. Blaszkowsky, Jeffrey W. Clark, Bruce J. Giantonio, Janet E. Murphy, Ryan David Nipp, Eric Roeland, David P. Ryan, Colin D. Weekes, Eunice L. Kwak, Jason E. Faris, Jennifer Y. Wo, François Aguet, Ipsita Dey‐Guha, Mehlika Hazar-Rethinam, Dora Dias‐Santagata, David T. Ting, Andrew X. Zhu, Theodore S. Hong, Todd R. Golub, A. John Iafrate, Viktor A. Adalsteinsson, Alberto Bardelli, Laxmi Parida, Dejan Juric, Gad Getz, Ryan B. Corcoran - Nature Medicine 2019 被引用: 522

  9. Molecular Mechanisms of Resistance to First- and Second-Generation ALK Inhibitors in ALK -Rearranged Lung Cancer

    著者: Justin F. Gainor, Leila Dardaei, Satoshi Yoda, Luc Friboulet, Ignaty Leshchiner, Ryohei Katayama, Ibiayi Dagogo‐Jack, Shirish M. Gadgeel, Katherine R. Schultz, Manrose Singh, Emily Chin, Melissa Parks, Dana Lee, Richard H. DiCecca, Elizabeth L. Lockerman, Tiffany G. Huynh, Jennifer Logan, Lauren L. Ritterhouse, Long P. Le, Ashok Muniappan, Subba R. Digumarthy, Colleen L. Channick, Colleen Keyes, Gad Getz, Dora Dias‐Santagata, Rebecca S. Heist, Jochen K. Lennerz, Lecia V. Sequist, Cyril H. Benes, A. John Iafrate, Mari Mino–Kenudson, Jeffrey A. Engelman, Alice T. Shaw - Cancer Discovery 2016 被引用: 1,144

  10. mRNA-based COVID-19 vaccine boosters induce neutralizing immunity against SARS-CoV-2 Omicron variant

    著者: Wilfredo F. García-Beltrán, Kerri St. Denis, Angelique Hoelzemer, Evan C. Lam, Adam D. Nitido, Maegan L. Sheehan, Cristhian Berrios, Onosereme Ofoman, Christina C. Chang, Blake M. Hauser, Jared Feldman, Alex Roederer, David J. Gregory, Mark C. Poznansky, Aaron G. Schmidt, A. John Iafrate, Vivek Naranbhai, Alejandro B. Balazs - Cell 2022 被引用: 1,098

  11. Polyclonal Secondary FGFR2 Mutations Drive Acquired Resistance to FGFR Inhibition in Patients with FGFR2 Fusion–Positive Cholangiocarcinoma

    著者: Lipika Goyal, Supriya K. Saha, Leah Y. Liu, Giulia Siravegna, Ignaty Leshchiner, Leanne G. Ahronian, Jochen K. Lennerz, Phuong Vu, Vikram Deshpande, Avinash Kambadakone, Benedetta Mussolin, Stephanie Reyes, Laura E. Henderson, Jiaoyuan Elisabeth Sun, Emily E. Van Seventer, Joseph M. Gurski, Sabrina Baltschukat, Barbara Schacher-Engstler, Louise Barys, Christelle Stamm, Pascal Furet, David P. Ryan, James R. Stone, A. John Iafrate, Gad Getz, Diana Graus Porta, Ralph Tiedt, Alberto Bardelli, Dejan Juric, Ryan B. Corcoran, Nabeel Bardeesy, Andrew X. Zhu - Cancer Discovery 2016 被引用: 545

  12. Crizotinib in ROS1-rearranged advanced non-small-cell lung cancer (NSCLC): updated results, including overall survival, from PROFILE 1001

    著者: A. Shaw, G.J. Riely, Yung‐Jue Bang, Donghyeon Kim, D.R. Camidge, Benjamin Solomon, Marileila Varella‐Garcia, A. John Iafrate, Geoffrey I. Shapiro, Tiziana Usari, Stewart C. Wang, Keith D. Wilner, Jeffrey W. Clark, S.‐H.I. Ou - Annals of Oncology 2019 被引用: 577

  13. Anchored multiplex PCR for targeted next-generation sequencing

    著者: Zongli Zheng, Matthew Liebers, Boryana Zhelyazkova, Yi Cao, Divya Panditi, Kerry D. Lynch, Juxiang Chen, Hayley Robinson, Hyo Sup Shim, Juliann Chmielecki, William Pao, Jeffrey A. Engelman, A. John Iafrate, Long P. Le - Nature Medicine 2014 被引用: 917

  14. TAS-120 Overcomes Resistance to ATP-Competitive FGFR Inhibitors in Patients with FGFR2 Fusion–Positive Intrahepatic Cholangiocarcinoma

    著者: Lipika Goyal, Lei Shi, Leah Y. Liu, Ferran Fece de la Cruz, Jochen K. Lennerz, Srivatsan Raghavan, Ignaty Leschiner, Liudmila Elagina, Giulia Siravegna, Raymond W.S. Ng, Phuong Vu, Krushna C. Patra, Supriya K. Saha, Raul N. Uppot, Ron Arellano, Stephanie Reyes, Takeshi Sagara, Sachie Otsuki, Brandon Nadres, Heather A. Shahzade, Ipsita Dey‐Guha, Isobel J. Fetter, Islam Baiev, Emily E. Van Seventer, Janet E. Murphy, Cristina R. Ferrone, Kenneth K. Tanabe, Vikram Deshpande, James J. Harding, Rona Yaeger, Robin Kate Kelley, Alberto Bardelli, A. John Iafrate, William C. Hahn, Cyril H. Benes, David T. Ting, Hiroshi Hirai, Gad Getz, Dejan Juric, Andrew X. Zhu, Ryan B. Corcoran, Nabeel Bardeesy - Cancer Discovery 2019 被引用: 371

  15. Clinical Features and Outcome of Patients With Non–Small-Cell Lung Cancer Who Harbor EML4-ALK

    著者: Alice T. Shaw, Beow Y. Yeap, Mari Mino–Kenudson, Subba R. Digumarthy, Daniel B. Costa, Rebecca S. Heist, Benjamin Solomon, Hannah Stubbs, Sonal Admane, Ultan McDermott, Jeffrey Settleman, Susumu Kobayashi, Eugene J. Mark, Scott J. Rodig, Lucian R. Chirieac, Eunice L. Kwak, Thomas J. Lynch, A. John Iafrate - Journal of Clinical Oncology 2009 被引用: 1,882

  16. ROS1 Rearrangements Define a Unique Molecular Class of Lung Cancers

    著者: Kristin Bergethon, Alice T. Shaw, Sai‐Hong Ignatius Ou, Ryohei Katayama, Christine M. Lovly, Nerina T. McDonald, Pierre P. Massion, Christina T. Siwak-Tapp, Adriana González, Rong Fang, Eugene J. Mark, Julie M. Batten, Haiquan Chen, Keith D. Wilner, Eunice L. Kwak, Jeffrey W. Clark, David P. Carbone, Hongbin Ji, Jeffrey A. Engelman, Mari Mino–Kenudson, William Pao, A. John Iafrate - Journal of Clinical Oncology 2012 被引用: 1,557

  17. RB loss in resistant EGFR mutant lung adenocarcinomas that transform to small-cell lung cancer

    著者: Matthew J. Niederst, Lecia V. Sequist, John T. Poirier, Craig H. Mermel, Elizabeth L. Lockerman, Angel R. Garcia, Ryohei Katayama, Carlotta Costa, Kenneth N. Ross, Teresa Morán, Emily Howe, Linnea Fulton, Hillary E. Mulvey, Lindsay A. Bernardo, Farhiya Mohamoud, Norikatsu Miyoshi, Paul A. VanderLaan, Daniel B. Costa, Pasi A. Jänne, Darrell R. Borger, Sridhar Ramaswamy, Toshi Shioda, A. John Iafrate, Gad Getz, Charles M. Rudin, Mari Mino–Kenudson, Jeffrey A. Engelman - Nature Communications 2015 被引用: 633

  18. The NCI-MATCH trial: lessons for precision oncology

    著者: Peter J. O’Dwyer, Robert J. Gray, Keith T. Flaherty, Alice P. Chen, Shuli Li, Victoria Wang, Lisa M. McShane, David R. Patton, James V. Tricoli, P. Mickey Williams, A. John Iafrate, Jeffrey Sklar, Edith P. Mitchell, Naoko Takebe, David Sims, Brent Coffey, Tony Fu, Mark J. Routbort, Larry Rubinstein, Richard F. Little, Carlos L. Arteaga, Donna M. Marinucci, Stanley R. Hamilton, Barbara A. Conley, Lyndsay N. Harris, James H. Doroshow - Nature Medicine 2023 被引用: 183

  19. Extreme Vulnerability of IDH1 Mutant Cancers to NAD+ Depletion

    著者: Kensuke Tateishi, Hiroaki Wakimoto, A. John Iafrate, Shota Tanaka, Franziska Loebel, Nina Lelic, Dmitri Wiederschain, Olivier Bedel, Gejing Deng, Bailin Zhang, Timothy He, Xu Shi, Robert E. Gerszten, Yiyun Zhang, Jing-Ruey Joanna Yeh, William T. Curry, Dan Zhao, Sudhandra Sundaram, Fares Nigim, Mara V.A. Koerner, Quan Van Ho, David E. Fisher, Elisabeth Roider, Lajos V. Kemény, Yardena Samuels, Keith T. Flaherty, Tracy T. Batchelor, Andrew S. Chi, Daniel P. Cahill - Cancer Cell 2015 被引用: 445

  20. Anaplastic Lymphoma Kinase Inhibition in Non–Small-Cell Lung Cancer

    著者: Eunice L. Kwak, Yung‐Jue Bang, D. Ross Camidge, Alice T. Shaw, Benjamin Solomon, Robert G. Maki, Sai‐Hong Ignatius Ou, Bruce J. Dezube, Pasi A. Jänne, Daniel B. Costa, Marileila Varella‐Garcia, Woo Ho Kim, Thomas J. Lynch, Panos Fidias, Hannah Stubbs, Jeffrey A. Engelman, Lecia V. Sequist, Weiwei Tan, Leena Gandhi, Mari Mino–Kenudson, Greg C. G. Wei, S. Martin Shreeve, Mark J. Ratain, Jeffrey Settleman, James G. Christensen, Daniel A. Haber, Keith D. Wilner, Ravi Salgia, Geoffrey I. Shapiro, Jeffrey W. Clark, A. John Iafrate - New England Journal of Medicine 2010 被引用: 4,504

  21. Polyclonal RB1 mutations and acquired resistance to CDK 4/6 inhibitors in patients with metastatic breast cancer

    著者: Rosaria Condorelli, Laura M. Spring, Joyce O’Shaughnessy, Ludovic Lacroix, Caroline Bailleux, Véronique Scott, Jon S. Dubois, Rebecca J. Nagy, Richard B. Lanman, A. John Iafrate, Fabrice André, Aditya Bardia - Annals of Oncology 2017 被引用: 404

  22. Sequential ALK Inhibitors Can Select for Lorlatinib-Resistant Compound ALK Mutations in ALK-Positive Lung Cancer

    著者: Satoshi Yoda, Jessica J. Lin, Michael S. Lawrence, Benjamin J. Burke, Luc Friboulet, Adam Langenbucher, Leila Dardaei, Kylie Prutisto-Chang, Ibiayi Dagogo‐Jack, Sergei Timofeevski, Harper Hubbeling, Justin F. Gainor, Lorin A. Ferris, Amanda K. Riley, Krystina E. Kattermann, Daria Timonina, Rebecca S. Heist, A. John Iafrate, Cyril H. Benes, Jochen K. Lennerz, Mari Mino–Kenudson, Jeffrey A. Engelman, Ted W. Johnson, Aaron N. Hata, Alice T. Shaw - Cancer Discovery 2018 被引用: 306

  23. Molecular Landscape and Actionable Alterations in a Genomically Guided Cancer Clinical Trial: National Cancer Institute Molecular Analysis for Therapy Choice (NCI-MATCH)

    著者: Keith T. Flaherty, Robert J. Gray, Alice P. Chen, Shuli Li, Lisa M. McShane, David R. Patton, Stanley R. Hamilton, P. Mickey Williams, A. John Iafrate, Jeffrey Sklar, Edith P. Mitchell, Lyndsay N. Harris, Naoko Takebe, David Sims, Brent Coffey, Tony Fu, Mark J. Routbort, James A. Zwiebel, Larry Rubinstein, Richard F. Little, Carlos L. Arteaga, Robert L. Comis, Jeffrey S. Abrams, Peter J. O’Dwyer, Barbara A. Conley, for the NCI-MATCH team - Journal of Clinical Oncology 2020 被引用: 295

  24. Ex vivo culture of circulating breast tumor cells for individualized testing of drug susceptibility

    著者: Min Yu, Aditya Bardia, Nicola Aceto, Francesca Bersani, Marissa W. Madden, Maria Donaldson Collier, Rushil Desai, Huili Zhu, Valentine Comaills, Zongli Zheng, Ben S. Wittner, Petar Stojanov, Elena F. Brachtel, Dennis C. Sgroi, Ravi Kapur, Toshi Shioda, David T. Ting, Sridhar Ramaswamy, Gad Getz, A. John Iafrate, Cyril H. Benes, Mehmet Toner, Shyamala Maheswaran, Daniel A. Haber - Science 2014 被引用: 913